Evaluation of the intravenous tranexamic acid effect on blood loss and surgical field quality during nasal surgery
Not Applicable
- Conditions
- heamorrhage.Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care During surgical operation
- Registration Number
- IRCT2013012911822N3
- Lead Sponsor
- Vice chancellor for Research and Technology, Hamadan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Nasal surgery; 18 to 65 years old; ASA = II
Exclusion criteria: Patient refuse; Surgery time less than 30 minutes; Renal dysfunction; Impaired color vision; Abnormal coagulation test; History of thrombosis or deep vein thrombosis; Ischemic heart disease and arrhythmia; Central nerve system disorder; Allergy to tranexamic acid; Usage Herbal medications; Pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Volume of blood in suction bottle. Timepoint: At end of surgery. Method of measurement: Viewing chamber volume per ml.;Quality of hemorrhage. Timepoint: each 20 min. Method of measurement: Boezzart criteria.;Hematocrit. Timepoint: Preoperative and six hours postoperative. Method of measurement: Automated Cell Counter.;Hemoglobin. Timepoint: Preoperative and six hours postoperative. Method of measurement: Automated Cell Counter.;Satisfactory of surgeon from bleeding. Timepoint: At end of surgery. Method of measurement: ask the surgeon.
- Secondary Outcome Measures
Name Time Method Impaired color vision. Timepoint: the day after sugery. Method of measurement: Ask the patient.;Nausea. Timepoint: The day after sugery. Method of measurement: Ask the patient.;Vomiting. Timepoint: The day after sugery. Method of measurement: Ask the patient.;Seizure. Timepoint: The day after sugery. Method of measurement: observation of the patient.